Drop in breast cancer cases in Australia follows fall in use of hormone replacement therapy

Sweet, Melissa
June 2008
BMJ: British Medical Journal (International Edition);6/14/2008, Vol. 336 Issue 7657, p1330
Academic Journal
The article focuses on research performed by the Cancer Council of New South Wales, the Australian National University and the University of Oxford which was reported in the "Medical Journal of Australia". The research found that a 40% decline in the use of hormone replacement therapy in Australia has been associated with a 6.7% decrease in the incidence of breast cancer among women aged 50 and over in the country. The research also found no significant change in the incidence of breast cancer among women younger than 50.


Related Articles

  • Family physician commentary. Shou Ling Leong // Journal of Family Practice;May2005, Vol. 54 Issue 5, p435 

    The article discusses about some aspects of hormone replacement therapy. Hormone replacement therapy (HRT) has generated fear and confusion among many women. While the absolute risk for diseases associated with hormone use is low, the diseases are devastating. Breast cancer and stroke are 2 of...

  • Clinical: Journals Watch - Breast cancer, diets and statins. Hope, Sally // GP: General Practitioner;12/10/2010, p22 

    The article reports on a follow-up data from a trial of 16,608 postmenopausal women who either had combined Hormone Replacement Therapy ( HRT ) with equine estrogens 0.625mg plus medroxyprogesterone acetate 2.5 mg per day, or placebo. Women on HRT had more invasive breast cancers than the...

  • The consumption of alcohol and its association with breast cancer: an update. Stockley, Creina // Australian & New Zealand Grapegrower & Winemaker;2008, Issue 537, p74 

    The article looks at various research which investigated the association between alcohol consumption and the risk of breast cancer in women. Around 100 population studies have observed the association in both pre- and post-menopausal women of all ages. It outlines the primary risk factors for...

  • Weigh HRT risks carefully says Cancer Research UK.  // Practice Nurse;5/26/2006, Vol. 31 Issue 10, p6 

    This article reports on the recommendations of the Cancer Research UK for post-menopausal women receiving long-term estrogen-only hormone replacement therapy (HRT). The recommendation follows new research that has confirmed that estrogen-only HRT slightly increases a woman's chances of...

  • KRAS rs61764370 is associated with HER2- overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study.  // BMC Cancer;2012, Vol. 12 Issue 1, p105 

    The article offers information on a study conducted by the authors related to association between KRAS oncogene KRAS rs61764370 and HER2-overexpressed breast cancer in those undergoing hormone replacement therapy. Genotyping of 530 sporadic postmenopausal breast cancer cases and 270...

  • Rising Rates of Invasive Lobular Cancer.  // Mayo Clinic Guide to Women's Cancers;2005, p40 

    The paper deals with the increasing incidence rates of invasive lobular carcinoma (ILC) in the U.S. ILC is a less common form of cancer that begins in the milk-producing glands of the breast. From 1987 to 1999, the proportion of all breast cancers that had a lobular component--either lobular...

  • Prescribing dilemmas Is HRT a safe option? Hope, Sally // Update;7/21/2005, Vol. 71 Issue 1, p30 

    The article focuses on the significance of hormone replacement therapy (HRT) for menopausal women. A postmenopausal breast cancer in a 70-year-old woman usually has no genetic link. In postmenopausal women, the biggest risk factor is obesity, since higher levels of estrogen are circulating from...

  • SHORT CUTS. Tonks, Alison // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;2/14/2009, p378 

    The article presents news items related to medicine. Research reported in "Lancet" suggests that patients with uncomplicated acute or subacute low back pain do not need lumbar imaging. Research reported in the "Journal of the American Medical Association" suggests that a new sedative called...

  • Breast cancer fell when women stopped hormone replacement. Tanne, Janice Hopkins // BMJ: British Medical Journal (International Edition);4/28/2007, Vol. 334 Issue 7599, p866 

    This article examines a report from the "New England Journal of Medicine" which found that breast cancer in 2003 in the United States dropped by more than 6 percent in women over 50 after women stopped using hormone replacement therapy. Incidence of breast cancer fell sharply in 2002 and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics